The CareUS test (WELLS Bio, South Korea) is designed for rapid qualitative detection of IgM and IgG antibodies to the COVID-19 coronavirus.
The test system identifies those who have been ill and have immunity, and also helps in confirming the diagnosis.
It has high accuracy and specificity.
- Specificity – 98%⠀
- Sensitivity - 94%⠀
- The result is 10 minutes.
The test system is approved by the FDA (US Food and Drug Administration) and Roszdravnadzor .
For reference:⠀
IgM antibodies indicate the active stage of the disease.⠀
IgG antibodies are produced after the acute phase of the disease and are an indicator of a previous or secondary infection .
You can also get a certificate of absence of COVID-19 from us.
